AX1 – Morgans rates the stock as Downgrade to Hold from Add

As a result of recent vaccine developments, Morgans lowers multiples (while largely leaving earnings unchanged) for those stocks likely to suffer from a return to some sense of normality (redirection of spend). 

The broker continues to think Christmas will be a boomer this year and first half results will show extraordinary growth with strong operating expense leverage on buoyant top-line trading. However, it’s considered the market will likely look through this strength.

Accent Group is yet to provide a trading update post its FY20 result (due at the AGM). Morgans expects trading outside of Melbourne has remained robust, with online the major driver.

Nonetheless, as a discretionary retailer, the broker expects the stock’s ability to outperform will be limited from here.

The rating is decreased to Hold from Add. The target price is decreased to $1.67 from $1.84

Sector: Retailing.

Target price is $1.67.Current Price is $1.65. Difference: $0.02 – (brackets indicate current price is over target). If AX1 meets the Morgans target it will return approximately 1% (excluding dividends, fees and charges – negative figures indicate an expected loss).

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →